AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 58.00
0.00 (0.00%)
At close: Feb 6, 2026
AnGes Market Cap
AnGes has a market cap or net worth of 22.56 billion as of February 6, 2026. Its market cap has increased by 50.50% in one year.
Market Cap
22.56B
Enterprise Value
19.18B
Revenue
818.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.00
Market Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 22.56B, a decrease of -3.41%. That is a compound annual growth rate of -0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 22.56B | -4.55% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healios K.K. | 46.99B |
| RaQualia Pharma | 26.14B |
| Japan Tissue Engineering | 21.85B |
| Renascience | 19.28B |
| StemRIM | 17.61B |
| CanBas | 17.37B |
| ReproCELL | 15.06B |
| Immuno-Biological Laboratories | 14.11B |